{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T18:51:54Z","timestamp":1794423114424,"version":"4.9.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.urolonc.2024.11.008","type":"journal-article","created":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T12:28:21Z","timestamp":1732364901000},"page":"199-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["State of the Art: The Microbiome in Bladder Cancer"],"prefix":"10.1016","volume":"43","author":[{"given":"Ilaha","family":"Isali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Almassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Nizam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Weight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghatalia","family":"Pooja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoniy","family":"Fulmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirtishri","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Abbosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bukavina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2024.11.008_bib0001","article-title":"Microbiome in cancer: an exploration of carcinogenesis, immune responses and immunotherapy","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.urolonc.2024.11.008_bib0002","article-title":"The urinary microbiome: role in bladder cancer and treatment","volume":"12","author":"Friedrich","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.urolonc.2024.11.008_bib0003","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.3389\/fmicb.2017.01162","article-title":"Geography, ethnicity or subsistence-specific variations in Human microbiome composition and diversity","volume":"8","author":"Gupta","year":"2017","journal-title":"Front Microbiol"},{"issue":"5","key":"10.1016\/j.urolonc.2024.11.008_bib0004","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1615\/CritRevImmunol.2019033233","article-title":"Impact of the microbiome on the immune system","volume":"39","author":"Lambring","year":"2019","journal-title":"Crit Rev Immunol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.11.008_bib0005","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3390\/ijms12010334","article-title":"The role of reactive-oxygen-species in microbial persistence and inflammation","volume":"12","author":"Spooner","year":"2011","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.urolonc.2024.11.008_bib0006","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3233\/BLC-200277","article-title":"The urinary microbiome and bladder cancer: susceptibility and immune responsiveness","volume":"6","author":"Andolfi","year":"2020","journal-title":"Bladder Cancer"},{"issue":"1","key":"10.1016\/j.urolonc.2024.11.008_bib0007","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29054-w","article-title":"The urinary microbiome associated with bladder cancer","volume":"8","author":"Bu\u010devi\u0107 Popovi\u0107","year":"2018","journal-title":"Scientific reports"},{"issue":"10","key":"10.1016\/j.urolonc.2024.11.008_bib0008","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1099\/jmm.0.001058","article-title":"Urinary microbiota - a potential biomarker and therapeutic target for bladder cancer","volume":"68","author":"Bi","year":"2019","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.urolonc.2024.11.008_bib0009","article-title":"Can smoking cause differences in urine microbiome in male patients with bladder cancer? a retrospective study","volume":"11","author":"Ma","year":"2021","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2024.11.008_bib0010","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.euo.2023.02.004","article-title":"Global meta-analysis of urine microbiome: colonization of polycyclic aromatic hydrocarbon-degrading bacteria among bladder cancer patients","volume":"6","author":"Bukavina","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urolonc.2024.11.008_bib0011","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fcimb.2018.00167","article-title":"Profiling the urinary microbiota in male patients with bladder cancer in China","volume":"8","author":"Wu","year":"2018","journal-title":"Front Cell Infection Microbiol"},{"key":"10.1016\/j.urolonc.2024.11.008_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.555508","article-title":"Alterations in urobiome in patients with bladder cancer and implications for clinical outcome: A single-institution study","volume":"10","author":"Zeng","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"10.1016\/j.urolonc.2024.11.008_bib0013","doi-asserted-by":"crossref","first-page":"370.e9","DOI":"10.1016\/j.urolonc.2020.12.011","article-title":"Investigating the association between the urinary microbiome and bladder cancer: an exploratory study","volume":"39","author":"Hussein","year":"2021","journal-title":"Urol Oncol"},{"issue":"6","key":"10.1016\/j.urolonc.2024.11.008_bib0014","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.euo.2020.04.002","article-title":"Sex-specific alterations in the urinary and tissue microbiome in therapy-na\u00efve urothelial bladder cancer patients","volume":"3","author":"Pederzoli","year":"2020","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.11.008_bib0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12894-020-0576-z","article-title":"Studying the urine microbiome in superficial bladder cancer: samples obtained by midstream voiding versus cystoscopy","volume":"20","author":"Hourigan","year":"2020","journal-title":"BMC Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.11.008_bib0016","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12915-014-0087-z","article-title":"Reagent and laboratory contamination can critically impact sequence-based microbiome analyses","volume":"12","author":"Salter","year":"2014","journal-title":"BMC Biol"},{"key":"10.1016\/j.urolonc.2024.11.008_bib0017","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1479-5876-10-174","article-title":"Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury","volume":"10","author":"Fouts","year":"2012","journal-title":"J Transl Med"},{"issue":"2","key":"10.1016\/j.urolonc.2024.11.008_bib0018","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s13577-021-00659-0","article-title":"Deciphering the influence of urinary microbiota on FoxP3+\u2009regulatory T cell infiltration and prognosis in Chinese patients with non-muscle-invasive bladder cancer","volume":"35","author":"Qiu","year":"2022","journal-title":"Human Cell"},{"issue":"16","key":"10.1016\/j.urolonc.2024.11.008_bib0019","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1002\/cam4.2419","article-title":"Dysbiosis signatures of the microbial profile in tissue from bladder cancer","volume":"8","author":"Liu","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.urolonc.2024.11.008_bib0020","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.csbj.2020.03.003","article-title":"The landscape of bacterial presence in tumor and adjacent normal tissue across 9 major cancer types using TCGA exome sequencing","volume":"18","author":"Rodriguez","year":"2020","journal-title":"Comput Struct Biotechnol J"},{"issue":"15","key":"10.1016\/j.urolonc.2024.11.008_bib0021","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13153649","article-title":"The bladder microbiome is associated with epithelial-mesenchymal transition in muscle invasive urothelial bladder carcinoma","volume":"13","author":"Li","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.urolonc.2024.11.008_bib0022","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.3389\/fphar.2018.01354","article-title":"Short-chain fatty acids, and herbal medicines","volume":"9","author":"Feng","year":"2018","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.urolonc.2024.11.008_bib0023","first-page":"395","article-title":"Gut microbial composition changes in bladder cancer patients: a case-control study in Harbin, China","volume":"29","author":"He","year":"2020","journal-title":"Asia Pac J Clin Nutr"},{"issue":"11","key":"10.1016\/j.urolonc.2024.11.008_bib0024","doi-asserted-by":"crossref","DOI":"10.3390\/genes13111967","article-title":"Integrated analysis of the fecal metagenome and metabolome in bladder cancer in a Chinese population","volume":"13","author":"Qin","year":"2022","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.urolonc.2024.11.008_bib0025","article-title":"Role of gut microbiome in neoadjuvant chemotherapy response in urothelial carcinoma: A multi-institutional prospective cohort evaluation","author":"Bukavina","year":"2023","journal-title":"BioRxiv"},{"issue":"15_suppl","key":"10.1016\/j.urolonc.2024.11.008_bib0026","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2021.39.15_suppl.4533","article-title":"Stool microbiota profiling of patients with muscle invasive bladder cancer receiving neoadjuvant pembrolizumab","volume":"39","author":"Pederzoli","year":"2021","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.11.008_bib0027","doi-asserted-by":"crossref","first-page":"11042","DOI":"10.1038\/s41598-020-67443-2","article-title":"Bladder cancer-related microbiota: examining differences in urine and tissue samples","volume":"10","author":"Mansour","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.urolonc.2024.11.008_bib0028","article-title":"Bladder cancer is associated with decreased urinary microbiota diversity and alterations in microbial community composition","author":"Hrb\u00e1\u010dek","year":"2022","journal-title":"Urol Oncol"},{"issue":"7","key":"10.1016\/j.urolonc.2024.11.008_bib0029","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.urolonc.2020.04.014","article-title":"Characterization of urinary microbiome in patients with bladder cancer: results from a single-institution, feasibility study","volume":"38","author":"Chipollini","year":"2020","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.11.008_bib0030","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/JU.0000000000001336","article-title":"The microbiome of catheter collected urine in males with bladder cancer according to disease stage","volume":"205","author":"Oresta","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2024.11.008_bib0031","article-title":"Profiling the bladder microbiota in patients with bladder cancer","volume":"12","author":"Parra-Grande","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.urolonc.2024.11.008_bib0032","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.euros.2022.06.005","article-title":"Human gut mycobiome and fungal community interaction: the unknown musketeer in the chemotherapy response status in bladder cancer","volume":"43","author":"Bukavina","year":"2022","journal-title":"Eur Urol Open Sci"},{"issue":"1","key":"10.1016\/j.urolonc.2024.11.008_bib0033","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00345-024-05173-0","article-title":"A review of urinary bladder microbiome in patients with bladder cancer and its implications in bladder pathogenesis","volume":"42","author":"Stamatakos","year":"2024","journal-title":"World J Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2024.11.008_bib0034","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/bju.12186","article-title":"Comparison of candidate scaffolds for tissue engineering for stress urinary incontinence and pelvic organ prolapse repair","volume":"112","author":"Mangera","year":"2013","journal-title":"BJU Int"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924007245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924007245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T03:43:00Z","timestamp":1741664580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143924007245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1078143924007245"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.11.008","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"State of the Art: The Microbiome in Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}